Home Other Building Blocks 112539-09-0
112539-09-0,MFCD00219329
Catalog No.:AA007AJA

112539-09-0 | 4-(2-Oxopyrrolidin-1-yl)benzenesulfonyl chloride

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
95%
in stock  
$95.00   $67.00
- +
1g
95%
in stock  
$211.00   $148.00
- +
5g
95%
in stock  
$610.00   $427.00
- +
10g
95%
in stock  
$1,009.00   $706.00
- +
25g
95%
in stock  
$2,007.00   $1,405.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA007AJA
Chemical Name:
4-(2-Oxopyrrolidin-1-yl)benzenesulfonyl chloride
CAS Number:
112539-09-0
Molecular Formula:
C10H10ClNO3S
Molecular Weight:
259.7093
MDL Number:
MFCD00219329
SMILES:
O=C1CCCN1c1ccc(cc1)S(=O)(=O)Cl
Properties
Computed Properties
 
Complexity:
368  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
16  
Hydrogen Bond Acceptor Count:
3  
Rotatable Bond Count:
2  
XLogP3:
1.4  

Downstream Synthesis Route

[1]Okolotowicz,KarlJ.;Dwyer,Mary;Ryan,Daniel;Cheng,Jiongjia;Cashman,EmilyA.;Moore,Stephanie;Mercola,Mark;Cashman,JohnR.[BioorganicandMedicinalChemistry,2018,vol.26,#15,p.4441-4451]

[2]Lin,Shu-Yu;Yeh,Teng-Kuang;Kuo,Ching-Chuan;Song,Jen-Shin;Cheng,Ming-Fu;Liao,Fang-Yu;Chao,Min-Wu;Huang,Han-Li;Chen,Yi-Lin;Yang,Chun-Yu;Wu,Mine-Hsine;Hsieh,Chia-Ling;Hsiao,Wenchi;Peng,Yi-Hui;Wu,Jian-Sung;Lin,Li-Mei;Sun,Manwu;Chao,Yu-Sheng;Shih,Chuan;Wu,Su-Ying;Pan,Shiow-Lin;Hung,Ming-Shiu;Ueng,Shau-Hua[JournalofMedicinalChemistry,2016,vol.59,#1,p.419-430]

[3]Gagné-Boulet,Mathieu;Bouzriba,Chahrazed;ChavezAlvarez,AtziriCorin;Fortin,Sébastien[EuropeanJournalofMedicinalChemistry,2021,vol.213]

[4]CurrentPatentAssignee:ROCHEHOLDINGAG-US2008/318941,2008,A1Locationinpatent:Page/Pagecolumn29

[5]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2009/23844,2009,A2Locationinpatent:Page/Pagecolumn91-92

[6]CurrentPatentAssignee:ROCHEHOLDINGAG-US2008/200471,2008,A1Locationinpatent:Page/Pagecolumn52

[7]CurrentPatentAssignee:ROCHEHOLDINGAG-US2010/16297,2010,A1Locationinpatent:Page/Pagecolumn30

[8]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2010/21797,2010,A1Locationinpatent:Page/Pagecolumn54

[9]CurrentPatentAssignee:ROCHEHOLDINGAG-US2010/29629,2010,A1Locationinpatent:Page/Pagecolumn47-48

[10]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2010/24980,2010,A1Locationinpatent:Page/Pagecolumn73

[11]CurrentPatentAssignee:ROCHEHOLDINGAG-US2010/22581,2010,A1Locationinpatent:Page/Pagecolumn41

[12]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2007/98418,2007,A1Locationinpatent:Page/Pagecolumn140-141

[1]JournalofMedicinalChemistry,2012,vol.55,p.7546-7559,14

[1]BioorganicandMedicinalChemistry,2018,vol.26,p.4441-4451

3476-89-9    112539-09-0   
C18H19N3O3S 

[1]BioorganicandMedicinalChemistry,2018,vol.26,p.4441-4451

13993-61-8    112539-09-0   
1-(4-(3,4-dihydro-1,5-naphthyridin-1(2H)-ylsulfonyl)phenyl)pyrrolidin-2-one 

[1]BioorganicandMedicinalChemistry,2018,vol.26,p.4441-4451

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:112539-09-0 Molecular Formula|112539-09-0 MDL|112539-09-0 SMILES|112539-09-0 4-(2-Oxopyrrolidin-1-yl)benzenesulfonyl chloride